Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Gabapentin 400 mg
NCT05436886Phase 1Completed
- Sponsor
- University of Karachi
- Start
- Jun 2013
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Gabament in epilepsy and neuropathic pain (2 arms), sponsored by University of Karachi. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve to the Last Measurable Concentration and 1 more. Started Jun 2013; status: completed.
02
Drugs
Gabament
03
Conditions
epilepsyneuropathic pain
Beyond the preview
Go deeper on NCT05436886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05436886.